Drug reference

finerenone

Mosby’s 2024 Nursing Drug Reference

Review source pages for extracted sections and age labels.

Overview

(fin-ER-e-none) Kerendia

PDF page 564

Func. class.: Nonsteroidal, mineralo- corticoid antagonist

PDF page 564

USES: Chronic kidney disease associ- ated with type 2 diabetes DOSAGES AND ROUTES • Adult: PO 10 or 20 mg daily based on eGFR

PDF page 564

Available forms: Tabs 10, 20 mg

PDF page 564

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

Drug reference

Mosby’s 2024 Nursing Drug Reference

Review source pages for extracted sections and age labels.

(fin-ER-e-none) Kerendia

PDF page 564

Func. class.: Nonsteroidal, mineralo- corticoid antagonist

PDF page 564

USES: Chronic kidney disease associ- ated with type 2 diabetes DOSAGES AND ROUTES • Adult: PO 10 or 20 mg daily based on eGFR

PDF page 564

Available forms: Tabs 10, 20 mg

PDF page 564

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.